PDI is upregulated in several types of cancer, including kidney, ovarian, prostate, lung, brain and germ-cell tumors, as well as lymphoma, and inhibition of its reductase activity by rutin has been associated with promising anticancer activity in vitro and in vivo [67,68]. Here, P4HB is linked to cancer.